{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:03:25Z","timestamp":1767967405058,"version":"3.49.0"},"publisher-location":"New York, NY","reference-count":62,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_26","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"471-486","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Lyme Subunit Vaccines: Design and Development of Peptide-Based Vaccine Candidates"],"prefix":"10.1007","author":[{"given":"Christina M.","family":"Small","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waithaka","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.","family":"Esteve-Gassent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"issue":"11","key":"26_CR1","doi-asserted-by":"publisher","first-page":"e113294","DOI":"10.1371\/journal.pone.0113294","volume":"9","author":"P Comstedt","year":"2014","unstructured":"Comstedt P, Hanner M, Schuler W, Meinke A, Lundberg U (2014) Design and development of a novel vaccine for protection against Lyme borreliosis. PLoS One 9(11):e113294","journal-title":"PLoS One"},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","volume":"3","author":"R Rappuoli","year":"2000","unstructured":"Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3:445\u2013450","journal-title":"Curr Opin Microbiol"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1128\/CVI.00406-14","volume":"21","author":"N Wressnigg","year":"2014","unstructured":"Wressnigg N, Barrett PN, Pollabauer EM, O'Rourke M, Portsmouth D et al (2014) A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato. Clin Vaccine Immunol 21:1490\u20131499","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"26_CR4","doi-asserted-by":"publisher","first-page":"e88245","DOI":"10.1371\/journal.pone.0088245","volume":"9","author":"CM Small","year":"2014","unstructured":"Small CM, Ajithdoss DK, Rodrigues Hoffmann A, Mwangi W, Esteve-Gassent MD (2014) Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against Lyme disease. PLoS One 9(2):e88245","journal-title":"PLoS One"},{"key":"26_CR5","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","volume":"74","author":"RU Palaniappan","year":"2006","unstructured":"Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF (2006) Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745\u20131750","journal-title":"Infect Immun"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/bmj.2.4726.251","volume":"2","author":"AW Downie","year":"1951","unstructured":"Downie AW (1951) Jenner\u2019s cowpox inoculation. Br Med J 2:251\u2013256","journal-title":"Br Med J"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0092-8674(00)80206-8","volume":"89","author":"JR Zhang","year":"1997","unstructured":"Zhang JR, Hardham JM, Barbour AG, Norris SJ (1997) Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275\u2013285","journal-title":"Cell"},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1128\/IAI.69.1.446-455.2001","volume":"69","author":"M Labandeira-Rey","year":"2001","unstructured":"Labandeira-Rey M, Skare JT (2001) Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69:446\u2013455","journal-title":"Infect Immun"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.183.1.271","volume":"183","author":"AM Silva de","year":"1996","unstructured":"de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E (1996) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183:271\u2013275","journal-title":"J Exp Med"},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268806007096","volume":"135","author":"LE Nigrovic","year":"2007","unstructured":"Nigrovic LE, Thompson KM (2007) The Lyme vaccine: a cautionary tale. Epidemiol Infect 135:1\u20138","journal-title":"Epidemiol Infect"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","author":"AC Steere","year":"1998","unstructured":"Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209\u2013215","journal-title":"N Engl J Med"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1073\/pnas.0305680101","volume":"101","author":"TA Willett","year":"2004","unstructured":"Willett TA, Meyer AL, Brown EL, Huber BT (2004) An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc Natl Acad Sci U S A 101:1303\u20131308","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26_CR13","first-page":"521","volume":"57","author":"AG Barbour","year":"1984","unstructured":"Barbour AG (1984) Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57:521\u2013525","journal-title":"Yale J Biol Med"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1084\/jem.99.2.167","volume":"99","author":"R Dulbecco","year":"1954","unstructured":"Dulbecco R, Vogt M (1954) Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med 99:167\u2013182","journal-title":"J Exp Med"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.4049\/jimmunol.137.10.3201","volume":"137","author":"G Antoni","year":"1986","unstructured":"Antoni G, Presentini R, Perin F, Tagliabue A, Ghiara P, Censini S, Volpini G, Villa L, Boraschi D (1986) A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol 137:3201\u20133204","journal-title":"J Immunol"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ttbdis.2011.04.002","volume":"2","author":"N Rudenko","year":"2011","unstructured":"Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr (2011) Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick-Borne Dis 2:123\u2013128","journal-title":"Ticks Tick-Borne Dis"},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/170.1.115","volume":"170","author":"SD Lovrich","year":"1994","unstructured":"Lovrich SD, Callister SM, Lim LC, DuChateau BK, Schell RF (1994) Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis 170:115\u2013121","journal-title":"J Infect Dis"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1128\/IAI.61.6.2532-2536.1993","volume":"61","author":"SK Kochi","year":"1993","unstructured":"Kochi SK, Johnson RC, Dalmasso AP (1993) Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments. Infect Immun 61:2532\u20132536","journal-title":"Infect Immun"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1128\/IAI.71.8.4432-4440.2003","volume":"71","author":"MB Lawrenz","year":"2003","unstructured":"Lawrenz MB, Wooten RM, Zachary JF, Drouin SM, Weis JJ, Wetsel RA, Norris SJ (2003) Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun 71:4432\u20134440","journal-title":"Infect Immun"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/MMBR.55.1.21-34.1991","volume":"55","author":"A Szczepanski","year":"1991","unstructured":"Szczepanski A, Benach JL (1991) Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol Rev 55:21\u201334","journal-title":"Microbiol Rev"},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1084\/jem.103.2.225","volume":"103","author":"AG Johnson","year":"1956","unstructured":"Johnson AG, Gaines S, Landy M (1956) Studies on the O antigen of Salmonella typhosa. V Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J Exp Med 103:225\u2013246","journal-title":"J Exp Med"},{"key":"26_CR22","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1128\/IAI.69.12.7437-7444.2001","volume":"69","author":"A Vaz","year":"2001","unstructured":"Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, Steere AC (2001) Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 69:7437\u20137444","journal-title":"Infect Immun"},{"key":"26_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1574-695X.1997.tb01068.x","volume":"19","author":"T Haupl","year":"1997","unstructured":"Haupl T, Landgraf S, Netusil P, Biller N, Capiau C, Desmons P, Hauser P, Burmester GR (1997) Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunol Med Microbiol 19:15\u201323","journal-title":"FEMS Immunol Med Microbiol"},{"key":"26_CR24","first-page":"45","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45\u2013148","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/JVI.55.3.836-839.1985","volume":"55","author":"EA Emini","year":"1985","unstructured":"Emini EA, Hughes JV, Perlow DS, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836\u2013839","journal-title":"J Virol"},{"key":"26_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","volume":"276","author":"AS Kolaskar","year":"1990","unstructured":"Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172\u2013174","journal-title":"FEBS Lett"},{"key":"26_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JE Larsen","year":"2006","unstructured":"Larsen JE, Lund O, Nielsen M (2006) Improved method for predicting linear B-cell epitopes. Immunome Res 2:2","journal-title":"Immunome Res"},{"key":"26_CR28","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/bi00367a013","volume":"25","author":"JM Parker","year":"1986","unstructured":"Parker JM, Guo D, Hodges RS (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25:5425\u20135432","journal-title":"Biochemistry"},{"key":"26_CR29","first-page":"105","volume":"73","author":"E Appella","year":"1995","unstructured":"Appella E, Padlan EA, Hunt DF (1995) Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules. EXS 73:105\u2013119","journal-title":"EXS"},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1021\/bc9801373","volume":"10","author":"DS Jones","year":"1999","unstructured":"Jones DS, Coutts SM, Gamino CA, Iverson GM, Linnik MD, Randow ME, Ton-Nu HT, Victoria EJ (1999) Multivalent thioether-peptide conjugates: B cell tolerance of an anti-peptide immune response. Bioconjug Chem 10:480\u2013488","journal-title":"Bioconjug Chem"},{"key":"26_CR31","first-page":"566","volume":"44","author":"P Montaguti","year":"1994","unstructured":"Montaguti P, Melloni E, Cavalletti E (1994) Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44:566\u2013570","journal-title":"Arzneimittelforschung"},{"key":"26_CR32","first-page":"614","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner PV, Pekow C, Vasbinder MA, Brabb T (2011) Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. J Am Assoc Lab Anim Sci 50:614\u2013627","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/00498254.2013.845706","volume":"44","author":"EA Thackaberry","year":"2014","unstructured":"Thackaberry EA, Wang X, Schweiger M, Messick K, Valle N, Dean B, Sambrone A, Bowman T, Xie M (2014) Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limits. Xenobiotica 44:235\u2013241","journal-title":"Xenobiotica"},{"key":"26_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ilar.43.4.207","volume":"43","author":"RB Dell","year":"2002","unstructured":"Dell RB, Holleran S, Ramakrishnan R (2002) Sample size determination. ILAR J 43:207\u2013213","journal-title":"ILAR J"},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/infdis\/162.1.133","volume":"162","author":"SW Barthold","year":"1990","unstructured":"Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD (1990) Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162:133\u2013138","journal-title":"J Infect Dis"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","volume":"10","author":"JD Radolf","year":"2012","unstructured":"Radolf JD, Caimano MJ, Stevenson B, Hu LT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87\u201399","journal-title":"Nat Rev Microbiol"},{"key":"26_CR37","first-page":"705","volume-title":"Biology of disease vectors","author":"KR Bouchard","year":"2004","unstructured":"Bouchard KR, Wikel SK (2004) Care, maintenance and experimental infestation of ticks in the laboratory setting. In: Marquart WC (ed) Biology of disease vectors, 2nd edn. Elsevier, New York, pp 705\u2013711","edition":"2"},{"key":"26_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/IAI.01118-07","volume":"76","author":"M Maruskova","year":"2008","unstructured":"Maruskova M, Esteve-Gassent MD, Sexton VL, Seshu J (2008) Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease. Infect Immun 76:391\u2013402","journal-title":"Infect Immun"},{"key":"26_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1074-7613(00)80341-6","volume":"6","author":"E Fikrig","year":"1997","unstructured":"Fikrig E, Barthold SW, Sun W, Feng W, Telford SR 3rd, Flavell RA (1997) Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity 6:531\u2013539","journal-title":"Immunity"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.154.4.1770","volume":"154","author":"A Keane-Myers","year":"1995","unstructured":"Keane-Myers A, Nickell SP (1995) T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol 154:1770\u20131776","journal-title":"J Immunol"},{"key":"26_CR41","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1086\/340826","volume":"185","author":"RR Montgomery","year":"2002","unstructured":"Montgomery RR, Lusitani D, de Boisfleury CA, Malawista SE (2002) Human phagocytic cells in the early innate immune response to Borrelia burgdorferi. J Infect Dis 185:1773\u20131779","journal-title":"J Infect Dis"},{"key":"26_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0169-4758(93)90176-G","volume":"9","author":"E Fikrig","year":"1993","unstructured":"Fikrig E, Kantor FS, Barthold SW, Flavell RA (1993) Protective immunity in Lyme borreliosis. Parasitol Today 9:129\u2013131","journal-title":"Parasitol Today"},{"key":"26_CR43","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1128\/IAI.68.9.5190-5197.2000","volume":"68","author":"MD McKisic","year":"2000","unstructured":"McKisic MD, Barthold SW (2000) T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun 68:5190\u20135197","journal-title":"Infect Immun"},{"key":"26_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/infdis\/164.1.123","volume":"164","author":"MM Simon","year":"1991","unstructured":"Simon MM, Schaible UE, Kramer MD, Eckerskorn C, Museteanu C, Muller-Hermelink HK, Wallich R (1991) Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis 164:123\u2013132","journal-title":"J Infect Dis"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1073\/pnas.032667699","volume":"99","author":"AT Revel","year":"2002","unstructured":"Revel AT, Talaat AM, Norgard MV (2002) DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A 99:1562\u20131567","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156\u2013159","journal-title":"Anal Biochem"},{"key":"26_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nprot.2006.83","volume":"1","author":"P Chomczynski","year":"2006","unstructured":"Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1:581\u2013585","journal-title":"Nat Protoc"},{"key":"26_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/bj0640405","volume":"64","author":"KS Kirby","year":"1956","unstructured":"Kirby KS (1956) A new method for the isolation of ribonucleic acids from mammalian tissues. Biochem J 64:405\u2013408","journal-title":"Biochem J"},{"key":"26_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/protein\/15.9.745","volume":"15","author":"M Cserzo","year":"2002","unstructured":"Cserzo M, Eisenhaber F, Eisenhaber B, Simon I (2002) On filtering false positive transmembrane protein predictions. Protein Eng 15:745\u2013752","journal-title":"Protein Eng"},{"key":"26_CR50","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature06387","volume":"450","author":"T Hessa","year":"2007","unstructured":"Hessa T, Meindl-Beinker NM, Bernsel A, Kim H et al (2007) Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 450:1026\u20131030","journal-title":"Nature"},{"key":"26_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-2105-10-159","volume":"10","author":"T Nugent","year":"2009","unstructured":"Nugent T, Jones DT (2009) Transmembrane protein topology prediction using support vector machines. BMC Bioinformatics 10:159","journal-title":"BMC Bioinformatics"},{"key":"26_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567\u2013580","journal-title":"J Mol Biol"},{"issue":"7","key":"26_CR53","doi-asserted-by":"publisher","first-page":"e40155","DOI":"10.1371\/journal.pone.0040155","volume":"7","author":"JS Chauhan","year":"2012","unstructured":"Chauhan JS, Bhat AH, Raghava GP, Rao A (2012) GlycoPP: a webserver for prediction of N- and O-glycosites in prokaryotic protein sequences. PLoS One 7(7):e40155","journal-title":"PLoS One"},{"key":"26_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nmeth.1701","volume":"8","author":"TN Petersen","year":"2011","unstructured":"Petersen TN, Brunak S, von Heijne G, Nielsen H (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8:785\u2013786","journal-title":"Nat Methods"},{"key":"26_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105\u2013132","journal-title":"J Mol Biol"},{"key":"26_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-3083.2005.01651.x","volume":"62","author":"R Boxio","year":"2005","unstructured":"Boxio R, Bossenmeyer-Pourie C, Vanderesse R, Dournon C, Nusse O (2005) The immunostimulatory peptide WKYMVm-NH activates bone marrow mouse neutrophils via multiple signal transduction pathways. Scand J Immunol 62:140\u2013147","journal-title":"Scand J Immunol"},{"key":"26_CR57","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T (2001) Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng 14:529\u2013532","journal-title":"Protein Eng"},{"key":"26_CR58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0968-4328(99)00036-0","volume":"30","author":"JR Harris","year":"1999","unstructured":"Harris JR, Markl J (1999) Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 30:597\u2013623","journal-title":"Micron"},{"key":"26_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0022-1759(82)90078-3","volume":"55","author":"FS Chu","year":"1982","unstructured":"Chu FS, Lau HP, Fan TS, Zhang GS (1982) Ethylenediamine modified bovine serum albumin as protein carrier in the production of antibody against mycotoxins. J Immunol Methods 55:73\u201378","journal-title":"J Immunol Methods"},{"key":"26_CR60","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3181\/00379727-37-9625","volume":"37","author":"J Freund","year":"1937","unstructured":"Freund J, Casals J, Hosmer EP (1937) Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 37:509\u2013513","journal-title":"Proc Soc Exp Biol Med"},{"key":"26_CR61","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","volume":"30","author":"DT O'Hagan","year":"2012","unstructured":"O'Hagan DT, Ott GS, De Gregorio E, Seubert A (2012) The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine 30:4341\u20134348","journal-title":"Vaccine"},{"key":"26_CR62","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/clinids\/2.3.370","volume":"2","author":"R Edelman","year":"1980","unstructured":"Edelman R (1980) Vaccine adjuvants. Rev Infect Dis 2:370\u2013383","journal-title":"Rev Infect Dis"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:53:39Z","timestamp":1692291219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_26","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}